David Bennett to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications David Bennett has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.786
-
Aducanumab and the "post-amyloid" era of Alzheimer research? Neuron. 2021 10 06; 109(19):3045-3047.
Score: 0.771
-
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.
Score: 0.016